Autologous Chimeric Antigen Receptor (CAR) T-cells Targeting the Kappa Myeloma Antigen (KMA) in Kappa Restricted Multiple Myeloma Patients With Relapsed/Refractory Disease
Clinical trial NCT07541391 · RECRUITING
Trial details
- NCT number
- NCT07541391
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-09-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.